DuPont de Nemours, Inc.
For the period ended Mar 31, 2026. Filed May 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Goodwill and Other Intangible Assets
NOTE 11 -GOODWILL AND OTHER INTANGIBLE ASSETS
The changes in the carrying amounts of goodwill during the three months ended March 31, 2026 were as follows:
| In millions | Healthcare & Water Technologies | Diversified Industrials | Total |
|---|---|---|---|
| Balance at December 31, 2025 | $4,399 | $3,516 | $7,915 |
| Currency translation adjustment | (39) | (11) | (50) |
| Balance at March 31, 2026 | $4,360 | $3,505 | $7,865 |
Q1 2026 Organizational Update
Effective in January 2026, Diversified Industrials realigned certain product lines. The realignment of the businesses within Diversified Industrials served as a triggering event requiring the Company to perform an impairment analysis related to goodwill carried by the impacted reporting units in January 2026. As part of the realignment, the Company assessed and re-defined certain reporting units effective January 2026, including reallocation of goodwill on a relative fair value basis. Goodwill impairment analyses were then performed for reporting units impacted in the Diversified Industrials segment. The results of the assessments indicated that it is not more likely than not that the fair values of the reporting units impacted were less than their carrying values. Therefore, no impairments were identified.
Q1 2025 Goodwill Impairment
The Company tests goodwill for impairment annually during the fourth quarter, or more frequently when events or changes in circumstances indicate that fair value is below carrying value. Effective in the first quarter of 2025, in preparation for the Electronics Separation, the Company realigned its management and reporting structure (the "Q1 2025 Segment Realignment"). In connection with the Q1 2025 Segment Realignment, the Company realigned its operating and reportable segments, which changed the composition of certain reporting units. During the first quarter of 2025, the associated reporting units' goodwill and indefinite-lived intangible assets were assessed for impairment before and after the Q1 2025 Segment Realignment.
After the Q1 2025 Segment Realignment, the Company performed quantitative testing on allsix reporting units. No impairments were identified except for the Aramids reporting unit (i.e., the aggregation of the Nomex® and Kevlar®). The Company concluded that the carrying amount of the Aramids reporting unit exceeded its fair value resulting in a non-cash goodwill impairment charge of $768 million. Due to the Aramids Divestiture, this charge is now reflected within discontinued operations.
Other Intangible Assets
The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows:
| March 31, 2026 | December 31, 2025 | |||||
|---|---|---|---|---|---|---|
| In millions | Gross Carrying Amount | Accum Amort | Net | Gross Carrying Amount | Accum Amort | Net |
| Intangible assets with finite lives: | ||||||
| Developed technology | $955 | $(540) | $415 | $1,004 | $(574) | $430 |
| Trademarks/tradenames | 541 | (309) | 232 | 546 | (305) | 241 |
| Customer-related | 3,096 | (1,307) | 1,789 | 3,155 | (1,315) | 1,840 |
| Other | 31 | (10) | 21 | 31 | (9) | 22 |
| Total other intangible assets with finite lives | $4,623 | $(2,166) | $2,457 | $4,736 | $(2,203) | $2,533 |
| Intangible assets with indefinite lives: | ||||||
| Trademarks/tradenames | $403 | $— | $403 | $403 | $— | $403 |
| Total other intangible assets | $403 | $— | $403 | $403 | $— | $403 |
| Total | $5,026 | $(2,166) | $2,860 | $5,139 | $(2,203) | $2,936 |
Total estimated amortization expense for the remainder of 2026 and the five succeeding fiscal years is as follows:
| Estimated Amortization Expense | |
|---|---|
| In millions | |
| Remainder of 2026 | $203 |
| 2027 | $257 |
| 2028 | $234 |
| 2029 | $216 |
| 2030 | $209 |
| 2031 | $209 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.